InflaRx NV(IFRX.US)

Last Updated 19:00:00 ET
longbridge loading

InflaRx Investor Update: Izicopan Set to Take Center Stage in AAV and Renal Disease Pipeline

Market Beat·
US
IFRX
-5.20%
US
SBIO
-1.24%
US
LABU
-2.35%
Market Beat·
US
IFRX
-5.20%
US
SBIO
-1.24%
US
LABU
-2.35%

InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares

Unusual Whales·
US
IFRX
-5.20%
US
BBH
+0.68%
US
FBT
+0.54%
Unusual Whales·
US
IFRX
-5.20%
US
BBH
+0.68%
US
FBT
+0.54%

InflaRx (NASDAQ:IFRX) Posts Earnings Results, Beats Estimates By $0.08 EPS

Market Beat·
US
IFRX
-5.20%
US
IBB
+0.10%
US
IBBQ
+0.07%
Market Beat·
US
IFRX
-5.20%
US
IBB
+0.10%
US
IBBQ
+0.07%

12 Industrials Stocks Moving In Wednesday's Intraday Session

benzinga_article·
US
GEO
-0.13%
US
BXC
-11.17%
US
CVGI
-4.56%
benzinga_article·
US
GEO
-0.13%
US
BXC
-11.17%
US
CVGI
-4.56%

InflaRx shares are trading higher after the company announced that it intends to develop izicopan, an oral C5a receptor inhibitor with potential best-in-class properties, in AAV, a life-threatening kidney disorder.

benzinga_article·
US
IFRX
-5.20%
benzinga_article·
US
IFRX
-5.20%

InflaRx Files Q1 2026 Financials with SEC via Form 6-K

Tip Ranks·
US
IFRX
-5.20%
US
IBBQ
+0.07%
US
LABU
-2.35%
Tip Ranks·
US
IFRX
-5.20%
US
IBBQ
+0.07%
US
LABU
-2.35%

InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases | IFRX Stock News

StockTitan·
US
IFRX
-5.20%
US
BBH
+0.68%
US
IBB
+0.10%
StockTitan·
US
IFRX
-5.20%
US
BBH
+0.68%
US
IBB
+0.10%

InfraRX Down Ahead of Next Quarterly Report

Baystreet·
US
IFRX
-5.20%
US
FBT
+0.54%
US
SBIO
-1.24%
Baystreet·
US
IFRX
-5.20%
US
FBT
+0.54%
US
SBIO
-1.24%

InflaRx to Report First Quarter 2026 Results on May 7, 2026 | IFRX Stock News

StockTitan·
US
IFRX
-5.20%
US
IBBQ
+0.07%
US
IBB
+0.10%
StockTitan·
US
IFRX
-5.20%
US
IBBQ
+0.07%
US
IBB
+0.10%

U.S. stock market mid-session update: InflaRx up 14.37%, successfully restored Nasdaq compliance, market confidence greatly increased!

Price Alert·
US
IFRX
-5.20%
Price Alert·
US
IFRX
-5.20%
© 2026 Longbridge｜Disclaimer